4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001577014-26-000006
Director sold 227,337 shares at an average $18.38 ($4,178,516)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rhodes Jason P Director | 2026-04-28 | Sale 10b5-1 | −59,870 | $18.38 | $1,100,411 | 1,577,432 | I |
| Rhodes Jason P Director | 2026-04-28 | Sale 10b5-1 | −119,115 | $18.38 | $2,189,334 | 4,939,489 | I |
| Rhodes Jason P Director | 2026-04-28 | Sale 10b5-1 | −1,170 | $18.38 | $21,505 | 8,512 | I |
| Rhodes Jason P Director | 2026-04-28 | Sale 10b5-1 | −47,082 | $18.38 | $865,367 | 1,158,944 | I |
| Rhodes Jason P Director | 2026-04-28 | Sale 10b5-1 | −26 | $19.00 | $494 | 1,577,406 | I |
| Rhodes Jason P Director | 2026-04-28 | Sale 10b5-1 | −52 | $19.00 | $988 | 4,939,437 | I |
| Rhodes Jason P Director | 2026-04-28 | Sale 10b5-1 | −1 | $19.00 | $19 | 8,511 | I |
| Rhodes Jason P Director | 2026-04-28 | Sale 10b5-1 | −21 | $19.00 | $399 | 1,158,923 | I |
| Open-market sales · 227,337 sh · avg $18.38 · $4,178,516 | |||||||
Loading xslF345X06/form4-04302026_090407.xml…